Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03046654
Other study ID # 0247-15-RMB
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date March 15, 2017
Est. completion date August 31, 2020

Study information

Verified date September 2020
Source Rambam Health Care Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cervical cerclage is an obstetric intervention used in women with poor obstetric histories. After recruiting the participant, Trans vaginal sonography will be used to examine cervical length and funneling. In addition vaginal examination will be performed to evaluate the cervix. After placing the cerclage, the participant will be invited every 4 weeks for a follow up evaluation session in order to examine the cervix and cerclage position. .


Description:

Cervical cerclage is an obstetric intervention used in women with poor obstetric histories due to late abortions, premature deliveries and painless dilatation. These 3 situations are usually due to cervical incompetence though can be caused by infection and other factors.

The cerclage is usually placed from 12-24 weeks of gestation depending on the indication and medical follow up during pregnancy. There are 2 methods for cerclage performance-McDonald and Shirodkar that have the same efficacy.

After recruiting the participant, Trans vaginal sonography will be used to examine cervical length and funneling. In addition vaginal examination will be performed to evaluate the cervix. After placing the cerclage, the participant will be invited every 4 weeks for a follow up evaluation session in order to examine the cervix and cerclage position. Each follow up will include a vaginal examination and trans vaginal sonography. The trans vaginal sonography will examine total cervical length, funneling, and the cerclage's distance from the inner and outer os' of the cervix.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date August 31, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 44 Years
Eligibility Inclusion Criteria:

- Women that have a cervical cerclage placed during pregnancy at the investigator's medical center.

Exclusion Criteria:

- Women that do not require cervical cerclage.

- Women that had a cervical cerclage placed at a different medical center.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Trans vaginal sonography
Trans vaginal sonography performed once every 4 weeks from the time of cerclage placement until the time of cerclage removal to evaluate cerclage position and distance from internal and external os'.
Vaginal examination
Vaginal examination performed once every 4 weeks from the time of cerclage placement until the time of cerclage removal to evaluate cervical conditions including cervical dilatation, cervical effacement and pressure on the cerclage.
Speculum examination
Speculum examination performed once every 4 weeks from the time of cerclage placement until the time of cerclage removal to evaluate cerclage position and vaginal bleeding.

Locations

Country Name City State
Israel Rambam health care campus Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gestational age at the time of delivery Gestational age at the time of delivery Up to 9 months
Secondary Gestational age at the time of the removal of the cervical cerclage Gestational age at the time of the removal of the cervical cerclage Up to 9 months
See also
  Status Clinical Trial Phase
Completed NCT03665688 - Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S® N/A